Cargando…

Synergistic Effect of Cyclosporin A and Verapamil in Overcoming Vincristine Resistance of Multidrug‐resistant Cultured Human Leukemia Cells

Reversal of vincristine (VCR) resistance by cyclosporin A (CyA) or the combination of CyA and verapamil (VER) was investigated by using four P‐glycoprotein (P‐gp)‐associated human multidrug‐resistant (MDR) cell lines (K562/ADM, KYO‐1, HEL and CMK). Drug sensitivity was expressed as 50% inhibitory co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishida, Yasushi, Shimada, Yasuhiro, Shimoyama, Masanori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1990
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918095/ https://www.ncbi.nlm.nih.gov/pubmed/2118896 http://dx.doi.org/10.1111/j.1349-7006.1990.tb02653.x

Ejemplares similares

Cyclosporin A and verapamil have different effects on energy metabolism in multidrug-resistant tumour cells.
por: Broxterman, H. J., et al.
Publicado: (1990)

Multidrug Resistance in Cultured Human Leukemia and Lymphoma Cell Lines Detected by a Monoclonal Antibody, MRK16
por: Ishida, Yasushi, et al.
Publicado: (1989)

Synergistic effect of ginsenoside Rg3 with verapamil on the modulation of multidrug resistance in human acute myeloid leukemia cells
por: KIM, SUNG SU, et al.
Publicado: (2014)

Polysaccharide-based nanoparticles for co-loading mitoxantrone and verapamil to overcome multidrug resistance in breast tumor
por: Xu, Yurui, et al.
Publicado: (2017)

A Novel Multidrug Resistance in Cultured Leukemia and Lymphoma Cells Detected by a Monoclonal Antibody to 85‐kDa Protein, MRK20
por: Ohtsu, Tomoko, et al.
Publicado: (1989)

Verapamil increases the sensitivity of primary human colorectal carcinoma tissue to vincristine.
por: Ince, P., et al.
Publicado: (1986)

In Vitro Activity of Rifampicin and Verapamil Combination in Multidrug-Resistant Mycobacterium tuberculosis
por: Demitto, Fernanda de Oliveira, et al.
Publicado: (2015)

Pharmacokinetic interaction between epirubicin and the multidrug resistance reverting agent D-verapamil.
por: Scheithauer, W., et al.
Publicado: (1993)

Correction: In Vitro Activity of Rifampicin and Verapamil Combination in Multidrug-Resistant Mycobacterium tuberculosis
por: Demitto, Fernanda de Oliveira, et al.
Publicado: (2015)

Bodipy-FL-Verapamil: A Fluorescent Probe for the Study of Multidrug Resistance Proteins
por: Rosati, Anna, et al.
Publicado: (2004)

Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosuppressive derivatives.
por: GavÃ©riaux, C., et al.
Publicado: (1989)

Verapamil sensitizes normal and neoplastic rodent intestinal tissues to the stathmokinetic effect of vincristine in vivo.
por: Ince, P., et al.
Publicado: (1988)

Vincristine‐resistant Human Cancer KB Cell Line and Increased Expression of Multidrug‐resistance Gene
por: Kohno, Kimitoshi, et al.
Publicado: (1988)

Correction to “Folic acid-conjugated liposomal vincristine for multidrug resistant cancer therapy”
por: Wang, Chenyu, et al.
Publicado: (2022)

Individual or combined effects of enalapril and verapamil on chronic cyclosporine nephrotoxicity in rats.
por: Lee, S. K., et al.
Publicado: (1999)

Chemosensitization to adriamycin by cyclosporin A and verapamil in human retinoblastoma cell lines.
por: Lee, T. W., et al.
Publicado: (1993)

Enhancement of Reversing Effect of Cyclosporin A on Vincristine Resistance by Anti‐P‐glycoprotein Monoclonal Antibody MRK‐16
por: Naito, Mikihiko, et al.
Publicado: (1993)

Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell line.
por: Twentyman, P. R., et al.
Publicado: (1987)

Transport of the multidrug resistance modulators verapamil and azidopine in wild type and daunorubicin resistant Ehrlich ascites tumour cells.
por: Sehested, M., et al.
Publicado: (1990)

Epigallocatechin‐3‐gallate sensitises multidrug‐resistant oral carcinoma xenografts to vincristine sulfate
por: Chen, Li, et al.
Publicado: (2020)

Self-Assembly Nanoparticles for Overcoming Multidrug Resistance and Imaging-Guided Chemo-Photothermal Synergistic Cancer Therapy
por: Gao, Haiyan, et al.
Publicado: (2020)

Nonspecifically enhanced therapeutic effects of vincristine on multidrug-resistant cancers when coencapsulated with quinine in liposomes
por: Xu, Yuzhen, et al.
Publicado: (2015)

Overcoming Multidrug Resistance in Cancer Stem Cells
por: Moitra, Karobi
Publicado: (2015)

Pharmacological Strategies for Overcoming Multidrug Resistance to Chemotherapy
por: Fedotcheva, T. A., et al.
Publicado: (2023)

Chemotherapeutic Activity of Pitavastatin in Vincristine Resistant B-Cell Acute Lymphoblastic Leukemia
por: Piktel, Debbie, et al.
Publicado: (2023)

Inhibition of vincristine binding to plasma membrane vesicles from daunorubicin-resistant Ehrlich ascites cells by multidrug resistance modulators.
por: Sehested, M., et al.
Publicado: (1989)

Multidrug Resistance-Associated Protein 1 (MRP1) mediated vincristine resistance: effects of N-acetylcysteine and Buthionine Sulfoximine
por: Akan, Ilhan, et al.
Publicado: (2005)

Multidrug Resistance‐associated Protein‐mediated Multidrug Resistance Modulated by Cyclosporin A in a Human Bladder Cancer Cell Line
por: Kim, Wun‐Jae, et al.
Publicado: (1995)

Verapamil as an Adjuvant Treatment for Drug-Resistant Epilepsy
por: Lakshmikanthcharan, S., et al.
Publicado: (2018)

Multifunctional Gold Nanoparticles Overcome MicroRNA Regulatory Network Mediated-Multidrug Resistant Leukemia
por: Deng, Rong, et al.
Publicado: (2019)

Co-Encapsulation of Mitoxantrone and β-Elemene in Solid Lipid Nanoparticles to Overcome Multidrug Resistance in Leukemia
por: Amerigos Daddy J.C., Kambere, et al.
Publicado: (2020)

Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid Leukemia
por: Labbozzetta, Manuela, et al.
Publicado: (2022)

Multidrug resistance circumvention by a new triazinoaminopiperidine derivative S9788 in vitro: definition of the optimal schedule and comparison with verapamil.
por: Julia, A. M., et al.
Publicado: (1994)

Inorganic Nanocarriers Overcoming Multidrug Resistance for Cancer Theranostics
por: Lin, Gan, et al.
Publicado: (2016)

Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance
por: Zhou, Lei, et al.
Publicado: (2018)

Synthesis and Anticancer Cytotoxicity of Azaaurones Overcoming Multidrug Resistance
por: Tóth, Szilárd, et al.
Publicado: (2020)

Overcoming Multidrug Resistance of Antibiotics via Nanodelivery Systems
por: Imran, Mohammad, et al.
Publicado: (2022)

Enhancement by Verapamil of Neocarzinostatin Action on Multidrug‐resistant Chinese Hamster Ovary Cells: Possible Release of Nonprotein Chromophore in Cells
por: Miyamoto, Yoichi, et al.
Publicado: (1991)

In silico identified targeted inhibitors of P-glycoprotein overcome multidrug resistance in human cancer cells in culture
por: Follit, Courtney A, et al.
Publicado: (2015)

Overcoming Multidrug Resistance in Human Cancer Cells by Natural Compounds
por: Nabekura, Tomohiro
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_illm1rjj13oi856ojm0fh6rjgk